Literature DB >> 12729904

Proteasome inhibitors induce intracellular protein aggregation and cell death by an oxygen-dependent mechanism.

Marilene Demasi1, Kelvin J A Davies.   

Abstract

Clone 9 liver cells incubated under aerobic conditions with the proteasome inhibitors lactacystin, clastro lactacystin beta-lactone, and tri-leucine vinyl sulfone, in the absence of an obvious oxidative challenge, underwent oxidative protein modifications, such as loss of solubility, formation of aggregates (predominantly by disulfide bridges), and increased carbonyl formation, similar to those seen with hydrogen peroxide treatment. These alterations were accompanied by modification of cell morphology and loss of cell viability. Remarkably, almost all of these modifications were prevented when cell incubation with proteasome inhibitors was performed under a 3% oxygen atmosphere instead of the 21% oxygen routinely used in cell culture experiments. Our results suggest an oxygen-dependent mechanism for the protein oxidation, protein aggregation, cellular dysfunction, and apoptosis induced by proteasome inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729904     DOI: 10.1016/s0014-5793(03)00353-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  Activation of chaperone-mediated autophagy during oxidative stress.

Authors:  Roberta Kiffin; Christopher Christian; Erwin Knecht; Ana Maria Cuervo
Journal:  Mol Biol Cell       Date:  2004-08-25       Impact factor: 4.138

Review 2.  Comparative Microarray Analysis Identifies Commonalities in Neuronal Injury: Evidence for Oxidative Stress, Dysfunction of Calcium Signalling, and Inhibition of Autophagy-Lysosomal Pathway.

Authors:  Yann Wan Yap; Roxana M Llanos; Sharon La Fontaine; Michael A Cater; Philip M Beart; Nam Sang Cheung
Journal:  Neurochem Res       Date:  2015-08-29       Impact factor: 3.996

3.  Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea.

Authors:  Aglaia Pappa; Tia Estey; Rizwan Manzer; Donald Brown; Vasilis Vasiliou
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

4.  Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: implications for p53 ubiquitination.

Authors:  O D Reyes-Hernández; A Mejía-García; E M Sánchez-Ocampo; M A Cabañas-Cortés; P Ramírez; L Chávez-González; F J Gonzalez; G Elizondo
Journal:  Biochem Pharmacol       Date:  2010-05-15       Impact factor: 5.858

5.  Fibroblasts From Longer-Lived Species of Primates, Rodents, Bats, Carnivores, and Birds Resist Protein Damage.

Authors:  Andrew M Pickering; Marcus Lehr; William J Kohler; Melissa L Han; Richard A Miller
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-07-28       Impact factor: 6.053

Review 6.  Senescence suppressors: their practical importance in replicative lifespan extension in stem cells.

Authors:  Eun Seong Hwang
Journal:  Cell Mol Life Sci       Date:  2014-07-23       Impact factor: 9.261

7.  Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimer's Disease and Related Tauopathies.

Authors:  Jane Kovalevich; Anne-Sophie Cornec; Yuemang Yao; Michael James; Alexander Crowe; Virginia M-Y Lee; John Q Trojanowski; Amos B Smith; Carlo Ballatore; Kurt R Brunden
Journal:  J Pharmacol Exp Ther       Date:  2016-03-15       Impact factor: 4.030

Review 8.  The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors.

Authors:  Mario Di Napoli; BethAnn McLaughlin
Journal:  Curr Opin Investig Drugs       Date:  2005-07

9.  The proteasome is an integral part of solar ultraviolet a radiation-induced gene expression.

Authors:  Betul Catalgol; Isabella Ziaja; Nicolle Breusing; Tobias Jung; Annika Höhn; Buket Alpertunga; Peter Schroeder; Niki Chondrogianni; Efstathios S Gonos; Isabelle Petropoulos; Bertrand Friguet; Lars-Oliver Klotz; Jean Krutmann; Tilman Grune
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

10.  Parkinson's disease: genetics and beyond.

Authors:  N N Inamdar; D K Arulmozhi; A Tandon; S L Bodhankar
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.